Abiogen focuses its activity on Licensing In in order to ensure dynamic development of the company through the identification and realization of business opportunities.
Abiogen Pharma’s entrepreneurial commitment and the resulting prospects are aimed at exploring strategic partnerships that can advance the product portfolio in therapeutic areas such as the musculoskeletal area, pediatrics, dermatology and the respiratory area.
Anika Therapeutics
Acido Ialuronico Cross-linkato / Cingal
Om Pharma
Lisato Batterico Liofilizzato / Broncho Munal
Almirall
Aceclofenac / Gladio
ImasMed
Acido Ialuronico Cross-linkato / Jonexa Up
Hisamitsu Pharmaceutical CO0.INC.
Ketoprofene cerotto medicato / Keplat
Organon Italia S.r.l.
Alendronato/Alendros
Galenica AB
Mometasone Furoato-Ovixan Mometasone Furoato-Ovison
Synthon B.V. (Microweg)
Etoricoxib / Quantico
Bened Biomedical LTD
PS23 probiotico